Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jeremy Levin
Biotech
Ovid staff shuffle reads like a who's who of Big Pharma
Ovid Therapeutics has announced a leadership shuffle and staff reductions as it pivots to focus on early-stage development.
Annalee Armstrong
Jul 9, 2021 9:50am
Ovid plans to shop with Takeda bucks after shedding lead asset
Apr 22, 2021 9:50am
Takeda brings an epilepsy med back into the fold
Mar 3, 2021 7:00am
Ovid flunks Angelman phase 3, leaving field wide open for rivals
Dec 2, 2020 7:56am
Takeda, Ovid plot next steps for rare epilepsy med
Sep 30, 2020 8:00am
Angelini lands EU rights to Ovid's phase 3 rare disease drug
Jul 13, 2020 7:00am
